Gyoengyosi Bugat Pal Koerhaz — Clinical Trial Site

34 Registered trials

12 Currently recruiting

Organisation

Gyoengyosi Bugat Pal Koerhaz

Location

Gyongyos, Hungary

Identifier

ORG-100048895

Address

Dozsa Gyorgy Utca 20-22, 3200, Hungary

Departments

-
Belgyógyászati Osztály
Borgyogyaszati szakrendeles
Bőrgyógyászati Szakrendelő
Department of Gastroenterology
Department of Psychiatric Rehabilitation
Department of Psychiatry
Dermatology
Endoszkópiai Laboratórium
Gasztroenterologia
Gasztroenterológiai Egység
HU10001: Gasztroenterológiai Egység
HU10002:Gasztroenterológiai Egység
N/A
Neurológiai Szakrendelés
Neurology
Psychiatry
Pszichiatria
Pszichiátriai rehabilitációs osztály
Rehabilitacios Elmegyogyaszati Osztaly

Clinical trials at this site (34)

Search interface

A Phase 2, Dose-Ranging Study of LY4100511 (DC-853) in Adult Participants with Moderate-to-Severe Plaque Psoriasis Ended

2024-512207-39-00 Plaque Psoriasis 4 2025-01-30
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended

2024-511557-21-00 Major Depressive Disorder (MDD) with Moderate-to-severe 5 2024-11-14
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejec… Ended

2023-508736-62-00 Heart failure (HF) with reduced ejection fraction (HFrE 4 2024-08-08
A Phase 2 Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejecti… Ended

2023-508737-13-00 chronic heart failure 4 2024-08-08
A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease Ended

2024-512756-38-00 Crohn`s Disease (CD) 4 2022-02-17
Phase 3 Open label clinical trial with oral Atogepant for the prevention of migraine Ended

2023-507096-21-00 Chronic or Episodic Migraine (Migraine without aura, mi 5 2021-08-16
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan… Ended

2024-513569-38-00 Crohn's Disease 10 2021-07-09
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Ended

2023-506918-45-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Ended

2023-506919-18-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 Moderate and Severe Atopic Dermatitis 5 2019-01-09